Last update 08 May 2025

Tribendimidine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
力卓
Target-
Action-
Mechanism-
Therapeutic Areas
Inactive Indication-
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
China (30 Apr 2004),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC28H32N6
InChIKeyXOIOGKHKNQYULW-UHFFFAOYSA-N
CAS Registry115103-15-6

External Link

KEGGWikiATCDrug Bank
-Tribendimidine-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Ascariasis
China
30 Apr 2004
Hookworm Infections
China
30 Apr 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
130
Placebo
(nhffiqhzqr) = ucamsgcusz sircjypalo (kerfubjtib )
-
16 Aug 2019
(nhffiqhzqr) = cqoiwshbeq sircjypalo (kerfubjtib )
Not Applicable
156
rzzquqgvwo(wtpqpsthfs) = Adverse events caused by tribendimidine were significantly less than praziquantel fbxaiijbqi (bvabxohxlt )
-
01 Aug 2014
Phase 2
125
ropnqejrmp(tayqojnwlb) = ymdztmrelk uuaoblpeql (nmhqjxnppm )
-
01 Feb 2011
Mefloquine-artesunate
ropnqejrmp(tayqojnwlb) = xmpudldsny uuaoblpeql (nmhqjxnppm )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free